Calidi Biotherapeutics -CW23CLDWWPreferred / convertible
13F holders, Q3 2024 (September 30)15holders
1new positions
0sold out
1famous investor
$0.01avg. 13F price*
At the end of Q3 2024, 15 institutions reported holding Calidi Biotherapeutics -CW23 (CLDWW) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were Polar Asset Management Partners Inc. ($30K), Driehaus Capital Management LLC ($9K) and Finepoint Capital LP ($9K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Calidi Biotherapeutics -CW23
- CUSIP
- 320703119
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $9K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 756,568 shares bought and 124,039 shares sold, net +632,529 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Polar Asset Management Partners Inc. | — | No change | 2,165,086 | $30K |
| Driehaus Capital Management LLC | — | New | 750,000 | $9K |
| Finepoint Capital LP | — | No change | 655,200 | $9K |
| 683 Capital Management, LLC | — | No change | 599,702 | $8K |
| Aristeia Capital, L.L.C. | — | No change | 494,400 | $7K |
| Nomura Holdings Inc. | — | No change | 467,818 | $6K |
| Shaolin Capital Management LLC | — | Reduce -26.6% | 330,547 | $4K |
| Cowen and Company, LLC | — | No change | 171,536 | $2K |
| Exos Asset Management LLC | — | No change | 105,000 | $1K |
| Citadel Advisors | — | Add +0.3% | 70,701 | $926 |
| Walleye Capital LLC | — | No change | 36,469 | $478 |
| Walleye Trading LLC | — | No change | 20,052 | $263 |
| Clear Street LLC | — | Add +279.0% | 6,617 | $87 |
| UBS Group AG | — | Add +38.4% | 5,398 | $70 |
| Flow Traders U.S. LLC | — | Reduce -28.6% | 11,427 | $0 |
"% of holder's portfolio" is CLDWW's weight in each manager's 13F, not the share of Calidi Biotherapeutics -CW23 the manager owns.